Get started
Author

Cédric Khoury

Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial
2018 · Lionnel Geoffrois, Laurent Martin, et al. · Journal of Clinical Oncology · 151
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial
2018 · Yungan Tao, Anne Auperin, et al. · Journal of Clinical Oncology · 77
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
2012 · Claire Vautravers Dewas, Philippe Maingon, et al. · Radiation Oncology · 32
PDF
Cetuximab-radiotherapy versus cetuximab-radiotherapy plus concurrent chemotherapy in patients with N0-N2a squamous cell carcinoma of the head and neck (SCCHN): Results of the GORTEC 2007-01 phase III randomized trial.
2016 · Jean Bourhis, xu Shan Sun, et al. · Journal of Clinical Oncology · 13
“Real-world” evaluation of 18F-Choline PET/CT practices in prostate cancer patients and impact on changes in therapeutic strategy
2019 · Vincent Niziers, Romain Boissier, et al. · Urologic Oncology Seminars and Original Investigations · 11
Radiothérapie avec modulation d’intensité pour les cancers de la tête et du cou : le standard
2011 · P. Maingon, G. Créhange, et al. · Cancer/Radiothérapie · 9
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial
2026 · Cécile Ortholan, Anne Aupérin, et al. · The Lancet Healthy Longevity · 6
PDF
Radiotherapy for central neurocytoma: A multicentric retrospective study in France
2024 · Guillaume Virbel, Charles-Henry Mallereau, et al. · Cancer/Radiothérapie · 5
Exclusive chemoradiotherapy without TURBT for frail and elderly patients with an invasive bladder cancer: Which platin fits better?
2011 · C. Khoury, E. Martin, et al. · Journal of Clinical Oncology · 3
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
2013 · Claire Dewas-Vautravers, Philippe Maingon, et al. · Journal of Clinical Oncology
Patterns of locoregional relapses for patients with esophageal cancer for whom exclusive chemoradiotherapy failed: A plea for dose escalation and elective nodal irradiation.
2013 · Cedric Chevalier, Noemie Vulquin, et al. · Journal of Clinical Oncology
Duration of Androgen Deprivation Combined With Radiation Therapy Does Not Jeopardize Time to Castration Resistance in Men With Unfavorable Intermediate- and High-Risk Prostate Cancer
2012 · G. Crehange, M. Gauthier, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
RCMI contre radiothérapie conformationnelle tridimensionnelle chez les patients traités pour un cancer du canal anal : quel bénéfice clinique ?
2012 · C. Dewas, P. Maingon, et al. · Cancer/Radiothérapie
Use of the slope of the DVH curve for predicting late rectal toxicity in IMRT for patients with localized prostate cancer.
2012 · Gilles Crehange, Paul M Walker, et al. · Journal of Clinical Oncology
6531 POSTER Impact of Planned Dose Distribution on Sites of Locoregional Failure for Oesophageal Cancer Patients After Exclusive Chemoradiotherapy
2011 · N. Vulquin, M. Gauthier, et al. · European Journal of Cancer
Works count: 16
Citation count: 307
H-index: 6
I10-index: 5
Year
Topic
Type